Zenas BioPharma, Inc.(ZBIO)
$27.93-0.08 (-0.29%)
ZBIO
Zenas BioPharma, Inc. financials statements
$27.93
At close:-0.08 (-0.29%)
Want to see ZBIO full AI Analyst Report?
Zenas BioPharma, Inc. (ZBIO) Income Statement
322 Followers
Zenas BioPharma, Inc. Income Statement
Last quarter (Q3 2026), Zenas BioPharma, Inc.'s total revenue was $10.00M. In Q3, Zenas BioPharma, Inc.'s net income was $-108.92M. See Zenas BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| $ 10.00M | $ 5.00M | $ 50.00M | $ 0.00 | |
| $ 10.00M | $ -134.14M | $ 50.00M | $ -61.69M | |
| $ 221.38M | $ 29.75M | $ 87.15M | $ 14.51M | |
| Depreciation and Amortization | $ 56.00K | $ 137.00K | $ 113.00K | $ 78.00K |
| $ -370.43M | $ -156.42M | $ -27.03M | $ -75.12M | |
| $ -211.38M | $ -163.89M | $ -37.15M | $ -76.20M | |
| $ -166.43M | $ 7.33M | $ 324.00K | $ -43.08M | |
| $ -377.82M | $ -156.56M | $ -36.82M | $ -119.28M | |
| $ -377.74M | $ -156.99M | $ -37.12M | $ -119.28M | |
| Per Share Metrics | ||||
| Basic EPS | $ -8.44 | $ -3.76 | $ -0.97 | $ -3.11 |
| Diluted EPS | $ -8.44 | $ -3.76 | $ -0.97 | $ -3.11 |
| Weighted Average Shares Outstanding | 44.73M | 41.79M | 38.32M | 38.32M |
| Weighted Average Shares Outstanding (Diluted) | 44.73M | 41.79M | 38.32M | 38.32M |
Currency in USD

